香港联交所最新资料显示，10月6日，主席兼执行董事蔡东晨增持石药集团(01093)200万股，每股作价 为9.645港元，总金额为1929万港元。增持后最新持股数目约为28.37亿股，最新持股比例为24.62%。 ...

智通财经APP获悉，香港联交所最新资料显示，10月6日，主席兼执行董事蔡东晨增持石药集团 (01093)200万股，每股作价为9.645港元，总金额为1929万港元。增持后最新持股数目约为28.37亿股， 最新持股比例为24.62%。 ...

智通财经APP获悉，狮子山集团(01127)、石药集团(01093)于2025年10月6日进行了最新股东权益披露。 备注：持股数变动有可能因供股、合股、拆股等情况引起，请注意对照实际情况进行辨别。 | 股票名称 | 机构名称 | 性质 | 变动前持股 | 变动后持股 | 持股比 | | --- | --- | --- | --- | --- | --- | | 狮子山集团 | 刘竹坚 | 好仓 | 3.60 亿股 | 3.62 亿股 | 46.99%(最新) | | (01127) | | | | | 46.70%(前次) | | 石药集团(01093) | 蔡东晨 | 好仓 | 28.34 亿股 | 28.35 亿股 | 24.61%(最新) | | | | | | | 24.59%(前次) | ...

| 股份代號: | 01093 | | --- | --- | | 上市法國名稱: | 石藥集國有限公 | | 日期 (日 / 月 / 年): | 06/09/2025 - 06 | 格隆汇10月6日丨根据联交所最新权益披露资料显示，2025年10月2日-10月3日，石药集团(01093.HK)获执行董事兼主席蔡东晨在场内以每股均价9.6238- 9.6383港元合计增持725.4万股，涉资约6989.8万港元。 增持后，蔡东晨最新持股数目为2,835,118,670股，持股比例由24.54%上升至24.61%。 | 表格序號 | 大股東/董事/最高行政人員名稱 作出披露的 買入 / 賣出或涉及的股每股的平均價 | | | | | 持有權益的股份數目 佔已發行的 有關事件的日 | | | --- | --- | --- | --- | --- | --- | --- | --- | | | | 原大 | 份數目 | | | (請參閱上述*註解)有投票權股 (日 / 月 / 年) | | | | | | | | | 份自分比 | | | | | | | | | ( % ) | | | DA20251003E00 ...

备注：持股数变动有可能因供股、合股、拆股等情况引起，请注意对照实际情况进行辨别。 | 股票名称 | 机构名称 | 性质 | 变动前持股 | 变动后持股 | 持股比 | | --- | --- | --- | --- | --- | --- | | 电子交易集团 | 聂凡淇 | 好仓 | 9804.00 万股 | 8522.00 万股 | 6.93%(最新) | | (08036) | | | | | 7.97%(前次) | | 电子交易集团 | Financial Data | 好仓 | 9804.00 万股 | 8522.00 万股 | 6.93%(最新) | | (08036) | Technologies Limited | | | | | | | | | | | 7.97%(前次) | | 神冠控股 | 周亚仙 | 好仓 | 16.27 亿股 | 16.31 亿股 | 50.50%(最新) | | (00829) | | | | | 50.37%(前次) | | 石药集团 | 蔡东晨 | 好仓 | 28.28 亿股 | 28.34 亿股 | 24.59%(最新) | | (01093) | | | | ...

香港联交所最新资料显示，10月2日，主席兼执行董事蔡东晨增持石药集团(01093)600万股，每股作价 为9.6383港元，总金额为5782.98万港元。增持后最新持股数目约为28.34亿股，最新持股比例为 24.59%。 ...

智通财经APP获悉，香港联交所最新资料显示，10月2日，主席兼执行董事蔡东晨增持石药集团 (01093)600万股，每股作价为9.6383港元，总金额为5782.98万港元。增持后最新持股数目约为28.34亿 股，最新持股比例为24.59%。 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年9月30日 | 狀態: 新提交 | | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | 公司名稱: | 石藥集團有限公司 | | | 呈交日期: | 2025年10月2日 | | | I. 法定/註冊股本變動 不適用 | | | FF301 第 1 頁 共 10 頁 v 1.1.1 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01093 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 11,521,951,732 | | 0 | | 11,521,951,732 | | 增加 / 減少 (-) | | | 50 ...

Major Events - Jinye International Group (08549) plans to issue 100 million shares from September 30 to October 6 [1] - Zhida Technology (02650) intends to globally issue 5.9789 million shares, expecting to list on October 10 [1] - CSPC Pharmaceutical Group (01093) received clinical trial approval for SYH2070 injection (double-stranded small interfering RNA drug) in China [1] - Mixue Group (02097) plans to invest in a fresh beer product company to seize opportunities in the fresh beer industry [1] - Shangshan Gold (01939) proposes a placement at a discount of approximately 19.88%, aiming to raise about HKD 245.8 million [1] - GC Construction (01489) sees a change in controlling interest with a buyout offer at a discount of about 45.91%, resuming trading on October 2 [1] - Times Financial Services Group (00510) major shareholder plans to sell some shares, resuming trading on October 2 [1] - Huajian Medical (01931) confidentially submitted an F-1 registration statement for a dual listing in the U.S. [1] - Ding Shi Capital (00804) intends to acquire 100% equity of a distressed asset disposal business, actively entering the distressed asset market [1] - Chuangmeng Tiandi (01119) plans to issue a total of 236 million shares [1] - Zhaogang Group-W (06676) intends to conduct a share buyback [1] - Daren International (01957) is exploring the possibility of acquiring up to 100 bitcoins [1] - Sihuan Pharmaceutical (00460) received approval from the National Medical Products Administration for its self-developed L-carnosine composite solution water light needle "Frozen Beauty" [1] Bonds and Notes - Minmetals Resources (01208) plans to issue USD 500 million zero-coupon convertible bonds maturing in 2030 [2] Share Buybacks - Tencent Holdings (00700) repurchased approximately 832,000 shares for about HKD 551 million on September 30 [2] - Midea Group (00300) spent approximately CNY 146 million to repurchase 2.0015 million A-shares on September 30 [2] - Anta Sports (02020) repurchased approximately 1.000 million shares for about HKD 99.87 million on September 30 [2] - SF Holding (06936) repurchased approximately 937,600 A-shares for about CNY 37.78 million on September 30 [2] - HSBC Holdings (00005) repurchased approximately 2.1133 million shares for about GBP 22.07 million on September 29 [2] Operating Performance - BYD Company (01211) reported approximately 3.2601 million new energy vehicle sales in the first nine months, a year-on-year increase of 18.64% [2] - Geely Automobile (00175) reported total vehicle sales of 273,100 units in September, a year-on-year increase of approximately 35% [2] - Great Wall Motors (02333) reported total vehicle sales of approximately 133,600 units in September, a year-on-year increase of 23.29% [2] - NIO Inc. (09866) delivered 34,749 vehicles in September, setting a new monthly record with a year-on-year increase of 64.1% [2] - Li Auto (02015) delivered 33,951 new vehicles in September [2]

格隆汇9月30日丨石药集团(01093.HK)公告，于2025年9月30日，公司间接非全资附属公司石药创新董事 会已批准于联交所主板的H股建议上市。预期紧随H股建议上市完成后，石药创新将仍为公司间接附属 公司。现时预期H股建议上市将涉及透过石药创新新H股于联交所主板首次公开发售进行提呈发售以供 认购，占紧随H股建议上市完成后石药创新经扩大已发行股本不超过10%(假设超额配股权未获行使)。 ...